Sort   by:  
 Page size 
UnknownProspective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers.
Not available
S-EPMC6944156 | biostudies-literature
UnknownRandomised trial of expressive writing for distressed metastatic breast cancer patients.
Not available
S-EPMC3175346 | biostudies-literature
UnknownThe Impact That Number of Analyzed Metastatic Breast Cancer Lesions Has on Response Assessment by 18F-FDG PET/CT Using PERCIST.
Not available
S-EPMC5493391 | biostudies-literature
UnknownAcquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence.
Not available
S-EPMC5393973 | biostudies-literature
UnknownComparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer.
Not available
S-EPMC5526620 | biostudies-literature
UnknownIncreased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
Not available
S-EPMC7339936 | biostudies-literature
UnknownPI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D.
Not available
S-EPMC5485411 | biostudies-literature
UnknownSingle-Dose Liposomal Amphotericin Plus Fluconazole and Flucytosine for Cryptococcal Meningitis at a US Public Hospital.
Not available
S-EPMC12824767 | biostudies-literature
UnknownClinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab.
Not available
S-EPMC7501177 | biostudies-literature
UnknownPDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition.
Not available
S-EPMC4982440 | biostudies-literature
Sort   by:  
 Page size